Geode Capital Management, LLC Reata Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $3.49 Million - $4.65 Million	44,117 Added 8.03%	593,430 $60.5 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $715,627 - $2.16 Million	23,197 Added 4.41%	549,313 $49.9 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $491,641 - $934,673	22,196 Added 4.4%	526,116 $20 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $233,987 - $439,886	12,055 Added 2.45%	503,920 $12.7 Million
Q2 2022 Aug 12, 2022	BUY	$20.71 - $36.5 $847,929 - $1.49 Million	40,943 Added 9.08%	491,865 $14.9 Million
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $281,215 - $461,696	-11,659 Reduced 2.52%	450,922 $14.8 Million
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $390,578 - $1.69 Million	-15,251 Reduced 3.19%	462,581 $12.2 Million
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $138,900 - $198,654	1,389 Added 0.29%	477,832 $48.1 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $11 Million - $21.2 Million	140,402 Added 41.78%	476,443 $67.4 Million
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $1.92 Million - $2.7 Million	20,319 Added 6.44%	336,041 $33.5 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $3.51 Million - $6.35 Million	34,400 Added 12.23%	315,722 $39 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $2.52 Million - $4.41 Million	-26,985 Reduced 8.75%	281,322 $27.4 Million
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $7.37 Million - $10.3 Million	-58,377 Reduced 15.92%	308,307 $48.1 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $3.42 Million - $6.83 Million	27,562 Added 8.13%	366,684 $52.9 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $3.37 Million - $9.84 Million	45,169 Added 15.37%	339,122 $69.3 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $3.77 Million - $5.07 Million	52,904 Added 21.95%	293,953 $23.6 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $1.95 Million - $2.36 Million	25,043 Added 11.59%	241,049 $22.7 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $1.23 Million - $2.41 Million	23,700 Added 12.32%	216,006 $18.5 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $534,312 - $837,629	10,958 Added 6.04%	192,306 $10.8 Million
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $1.42 Million - $3.68 Million	39,926 Added 28.23%	181,348 $14.8 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $542,188 - $1.11 Million	27,191 Added 23.8%	141,422 $4.95 Million
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $1,660 - $2,505	83 Added 0.07%	114,231 $2.34 Million
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $406,199 - $603,584	18,142 Added 18.9%	114,148 $3.23 Million
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $727,864 - $882,629	27,686 Added 40.52%	96,006 $2.99 Million
Q2 2017 Aug 14, 2017	BUY	N/A	68,320	68,320 $2.16 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account